Antineoplastica 2024 Tender, Czech Republic - 98343150

Procurement Summary

Country : Czech Republic

Summary : Antineoplastica 2024

Deadline : 05 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 98343150

Document Ref. No. : 138488-2024

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : CZK 4836000

Purchaser's Detail

Purchaser : UNIVERSITY HOSPITAL IN PILSEN
Address: Edvarda Beneše 1128
Town: Plzeň
NUTS-Code: CZ032
Postal Code: 30100
Phone: 420 603366059
Czech Republic
Email :kozak@fnplzen.cz
URL :https://www.fnplzen.cz

Tender Details

The subject of the public contract is the supply of medicinal products intended for the therapy of malignant diseases in the total expected volume of 100, 552 individual doses of medicinal products.

Delivery of the subject of performance budou implemented on the basis of the results of the completed procurement procedure for a period of four years from the signing of the purchase contract.

Cytostatic drug containing the active substance pomalidomide

P.o. form containing 2 mg of pomalidomide per form unit, estimated annual volume of 630 form units (doses); after. the form containing 4 mg slowlydomid in a form unit, expected annual volume of 2, 730 form units (doses); ATC L04AX06

Cytostatic drug containing the active substance cetuximab

Ampoule containing 100 mg of cetuximab, estimated annual volume of 1, 220 ampoules (dose); ampoule containing 500 mg cetuximab, expected annual volume of 540 ampoules (doseek); ATC L01FE01

Cytostatic agent containing the active substance palbociclib

P.o. form containing 125 mg of palbociclib per form unit, estimated annual volume of 3, 780 form units (doses); ATC L01EF01

Cytostatic agent containing the active substance axitinib

P.o. form containing 1 mg of axitinib per form unit, estgiven annual volume of 3, 640 units of form (dosage); ATC L01EK01

Cytostatic agent containing the active substance cabozantinib

P.o. form containing 20 mg of cabozantinib per form unit, estimated annual volume of 600 form units (doses); after. form containing 40 mg of cabozantinib per form unit, estimated annual...
Document Type: Contract Notice
Reference Number: 29/24
Contract Type: supplies
Estimated Value: 4836000 - CZK
Authority Type: pub-undert-cga
Doc Title: Antineoplastika 2024
Dispatch Date: 2024-03-05
Publish Date: 2024-03-06
Submission Date: 2024-04-05

Documents

 Tender Notice